Background: Although it is well known that valvular lesions show changes in stiffness, this fact has not been studied objectively or quantitatively.
Methods: Using a tactile sensor, stiffness of the mitral valve was measured at 11 autopsies and 19 surgically excised specimens. The relationships between stiffness and histological state were investigated in 394 points of resected specimens.
Results: In normal mitral valves, the anterior leaflet was significantly stiffer than the posterior leaflet in all zones. The rough zone had the least stiffness in both leaflets. Mitral stenotic valves were significantly stiffer than normal in all zones, the rough zone had the greatest stiffness. The grade of fibrosis (r=0.862), hyalinosis (r=0.783), and calcification (r=0.464) had positive correlation with the stiffness, respectively. An S score that was composed of these three factors had strong positive correlation (r=0.935). The regression equation was: stiffness=2.882+2.304xS score (r(2)=0.88). With cut-off values of 8 g/cm for severe fibrosis, 10 for focal hyalinosis, 13 for diffuse hyalinosis, 15 for mild calcification and 18 for massive calcification, these changes were accurately (>90%) detected. The grade of myxoid change had mild negative correlation with the stiffness (r=-0.507).
Conclusion: The actual value of stiffness of normal and abnormal mitral valves and the relationships between stiffness and histological changes were obtained. A tactile sensor promptly and accurately shows stiffness of the heart valve indicating its histological state. It can be a useful device for cardiovascular surgery.
Download full-text PDF |
Source |
---|
Eur Heart J Cardiovasc Imaging
December 2024
Division of Radiology, Severance Cardiovascular Hospital, Yonsei University College of Medicine, Seoul, South Korea.
Aims: This study compared echocardiography (echo) and cardiac computed tomography (CT) in measuring the Wilkins score and evaluated the potential added benefit of CT in predicting immediate percutaneous mitral valvuloplasty (PMV) outcomes in rheumatic mitral stenosis (MS) patients deemed eligible for PMV by echo.
Methods And Results: From a multicentre registry of 3,140 patients with at least moderate MS, we included 96 patients (age 56.4±11.
Echocardiography
January 2025
Cardiovascular Imaging Unit, Cardiothoracic Department, IRCCS San Raffaele Hospital, Milan, Italy.
Cureus
November 2024
Cardiovascular Surgery, Sapporo Medical University, Sapporo, JPN.
We report a 75-year-old female with a history of two heart operations: aortic valve replacement (St. Jude Medical 21 mm) at the age of 44 years for severe rheumatic aortic stenosis and mitral valve replacement (Carbomedics 29 mm) at the age of 51 years for rheumatic mitral regurgitation. Decades later, she presented with exertional dyspnea.
View Article and Find Full Text PDFCureus
November 2024
Internal Medicine, Shri Ram Murti Smarak Institute of Medical Sciences, Bareilly, IND.
Introduction The study aimed to retrospectively evaluate the early patient outcome and left ventricular function after mitral valve replacement with a tilting disc valve and total preservation. Patients and methods This retrospective observational study includes patients who underwent mitral valve replacement using a tilting disc valve with total preservation of mitral valvular and subvalvular apparatus from July 2021 to August 2022 at a single center. Results The data were reviewed retrospectively for age, sex, comorbidities, operating time, aortic cross-clamp time, cardiopulmonary bypass time, preoperative and postoperative left ventricular ejection fraction, mean gradient across the mitral valve, left ventricular diameter, left atrial size, atrial fibrillation, complications, mortality, and early patient outcome.
View Article and Find Full Text PDFCureus
November 2024
Cardiology, Mount Sinai West Hospital, New York, USA.
The mechanism and severity of mitral valve (MV) regurgitation (MR) play a critical role in guiding treatment decisions. Transthoracic echocardiography (TTE) is the primary diagnostic modality for evaluating MV disease. Discordant findings on TTE can be further quantified through transesophageal echocardiography (TEE).
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!